Harmindar K. Gill

580 total citations
5 papers, 422 citations indexed

About

Harmindar K. Gill is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Harmindar K. Gill has authored 5 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Harmindar K. Gill's work include Breast Lesions and Carcinomas (2 papers), MRI in cancer diagnosis (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Harmindar K. Gill is often cited by papers focused on Breast Lesions and Carcinomas (2 papers), MRI in cancer diagnosis (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Harmindar K. Gill collaborates with scholars based in United States and United Kingdom. Harmindar K. Gill's co-authors include Mary McPartlin, K.W. Chiu, B Higley, Laurie L. Fajardo, Cheryl R. Herman, John S. Eng, Wendie A. Berg, Naresh C. Gupta, Harry A. Bishop and Olga B. Ioffe and has published in prestigious journals such as Radiology, CHEST Journal and American Journal of Roentgenology.

In The Last Decade

Harmindar K. Gill

5 papers receiving 407 citations

Peers

Harmindar K. Gill
Teruhiko Takayama Japan
Y. Oussoren Netherlands
Suraj P. Bakshi United States
P. H. Cox Netherlands
Youmin Guo China
Manuel Sánchez-García Spain
Kristina Norrgren Sweden
Masashi Yukihiro Japan
N Molea Italy
Robert R. Shenk United States
Teruhiko Takayama Japan
Harmindar K. Gill
Citations per year, relative to Harmindar K. Gill Harmindar K. Gill (= 1×) peers Teruhiko Takayama

Countries citing papers authored by Harmindar K. Gill

Since Specialization
Citations

This map shows the geographic impact of Harmindar K. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harmindar K. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harmindar K. Gill more than expected).

Fields of papers citing papers by Harmindar K. Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harmindar K. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harmindar K. Gill. The network helps show where Harmindar K. Gill may publish in the future.

Co-authorship network of co-authors of Harmindar K. Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Harmindar K. Gill. A scholar is included among the top collaborators of Harmindar K. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harmindar K. Gill. Harmindar K. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Gill, Harmindar K., Olga B. Ioffe, & Wendie A. Berg. (2003). When Is a Diagnosis of Sclerosing Adenosis Acceptable at Core Biopsy?. Radiology. 228(1). 50–57. 40 indexed citations
2.
Herman, Cheryl R., Harmindar K. Gill, John S. Eng, & Laurie L. Fajardo. (2002). Screening for Preclinical Disease: Test and Disease Characteristics. American Journal of Roentgenology. 179(4). 825–831. 81 indexed citations
3.
Gill, Harmindar K. & Wendie A. Berg. (2001). Case 39: Invasive Lobular Carcinoma. Radiology. 221(1). 132–136. 5 indexed citations
4.
5.
Higley, B, et al.. (1993). Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.. PubMed. 34(2). 222–7. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teruhiko Takayama Breakdown of academic impact, for papers by Y. Oussoren Breakdown of academic impact, for papers by Suraj P. Bakshi Breakdown of academic impact, for papers by P. H. Cox Breakdown of academic impact, for papers by Youmin Guo Breakdown of academic impact, for papers by Manuel Sánchez-García Breakdown of academic impact, for papers by Kristina Norrgren Breakdown of academic impact, for papers by Masashi Yukihiro Breakdown of academic impact, for papers by N Molea Breakdown of academic impact, for papers by Robert R. Shenk
Rankless by CCL
2026